IMBROGNO EDWARD enters PDL BIOPHARMA, INC. with 22.36K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/24/2019ACC: 0000882104-19-000065
Officer· VP, Finance and CAO
Since Jun 2019
22.36K
Baseline shares
100% direct
22.36K
Direct ownership
1 position
397.38K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common stock
DirectShares owned22.36K
Total
22.36K direct22.36K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 22.36K | Direct |
| Total | 22.36K | 22.36K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common stock
Underlying shares
288.61K
Shares owned
N/A
Exercise price
2.68
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common stock
Underlying shares
108.77K
Shares owned
N/A
Exercise price
3.69
Expiration
—
Exercise window
—
Total
Underlying
397.38K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common stock | 2.68 | — | — | 288.61K | N/A |
| Stock Option (right to buy) Direct | Common stock | 3.69 | — | — | 108.77K | N/A |
| Total | 397.38K | 0.00 | ||||